Sabzevari Helen reported option exercise involving 250,000 shares of PRECIGEN, INC. on May 23, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
President and CEO
President and CEO
Filed May 27, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
—Shares × reported price
Shares traded
250,000Common Stock
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
3,888,122Direct
Trade date
May 23, 2026Option exercise
Filed
May 27, 2026, 8:18 PM ET5-day reporting delay
Accession
0000950103-26-007842Code M · Transaction 91648
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
May 23, 2026Option exercise250,000$0.00$0Trade 91649
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

PGEN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
PGEN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −12%1w ago −2%1d ago −6%
Returns since7d −14%30d +30%90d +62%180d1y

Footnotes in full

F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock. F2: Represents 50% of the RSUs granted on June 26, 2025 that vested on May 23, 2026. The remaining RSUs will vest in equal quarterly installments for three years thereafter.